How do lidocaine (5% lidocaine) patches, Salonpas (menthol/methyl‑salicylate ± lidocaine) patches, and high‑dose capsaicin (8% capsaicin) patches compare in indications, dosing, and safety for peripheral neuropathic and musculoskeletal pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Topical Analgesic Patches: Lidocaine vs Salonpas vs Capsaicin

For neuropathic pain, use lidocaine 5% patches as first-line therapy for postherpetic neuralgia and consider capsaicin 8% patches for more severe or refractory peripheral neuropathic pain; for musculoskeletal pain, Salonpas (menthol/methyl salicylate) patches are appropriate for mild-to-moderate pain but lack the evidence base of the other options.

Indications & Evidence Hierarchy

Lidocaine 5% Patches

Strongest evidence for neuropathic pain conditions, particularly postherpetic neuralgia where it has FDA approval 1. The evidence supports efficacy in:

  • Postherpetic neuralgia (FDA-approved, strong evidence) 2, 3
  • Diabetic peripheral neuropathy (moderate evidence, off-label) 4
  • HIV-associated peripheral neuropathy (can be used as adjunct) 5
  • Localized neuropathic pain with allodynia 2

The 2023 Mayo Clinic guideline specifically recommends lidocaine patches for erythromelalgia pain, noting they can be worn 12-24 hours and are "particularly practical for use on the dorsal or plantar surface of the feet" 6. A case series showed most patients improved with 5% patches after failing lidocaine gel 6.

Capsaicin 8% Patches

Strongest evidence for severe peripheral neuropathic pain with high-quality data 5:

  • HIV-associated peripheral neuropathy (strong recommendation, high-quality evidence) 5
  • Postherpetic neuralgia (strong evidence) 3, 4
  • Diabetic peripheral neuropathy (strong evidence) 4

The 2017 HIV/IDSA guideline gives capsaicin 8% a strong recommendation with high-quality evidence, noting "a single 30-minute application can provide pain relief for at least 12 weeks" 5. The 2025 Lancet meta-analysis calculated NNT=13.2 with NNH=1129.3 (moderate certainty) 3.

Critical caveat: Erythema and pain are common during application; pretreat with 4% lidocaine for 60 minutes before applying capsaicin 5.

Salonpas Patches (Menthol 3%/Methyl Salicylate 10%)

FDA-approved for mild-to-moderate musculoskeletal pain 7:

  • Sore muscles, sprains, backache, joint pain
  • Apply for 8-12 hours
  • Do not use more than one patch at a time (FDA label warning)

No guideline-level evidence for neuropathic pain. This is a counterirritant/rubefacient mechanism, fundamentally different from lidocaine's sodium channel blockade or capsaicin's TRPV1 receptor defunctionalization 8.

Dosing & Administration

Lidocaine 5% Patches

  • Up to 3-4 patches per 24 hours (safe systemic levels documented) 1
  • Apply for 12 hours on, 12 hours off (standard) or up to 24 hours continuously 6
  • Available OTC at 4% or prescription 5% strength 6
  • The newer 1.8% lidocaine system is bioequivalent to 5% but with superior adhesion 9

Capsaicin 8% Patches

  • Single 30-60 minute application by trained healthcare provider 5
  • Pretreat with lidocaine 4% for 60 minutes, wipe off before capsaicin application 5
  • Duration of effect: up to 12 weeks 5
  • Can repeat if first application fails—in one study, 6 of 8 non-responders improved 50% after second patch 10
  • 54-58% of patients experience burning sensations (moderate-to-high intensity, lasting ~2 days) 10

Salonpas Patches

  • One patch for 8-12 hours 7
  • Maximum one patch at a time (FDA label)
  • For temporary relief only

Safety Profile

Lidocaine 5% Patches

Excellent safety profile with minimal systemic absorption 1:

  • Adverse effects: mild local skin reactions, rare rash
  • No drug-drug interactions 1
  • Contraindication: advanced liver failure (decreased lidocaine clearance) 1
  • Particularly advantageous in older adults and patients with polypharmacy 11

Capsaicin 8% Patches

  • Common: erythema, burning pain at application site (54-58% of patients) 10
  • Duration of burning: typically 2 days, moderate-to-high intensity 10
  • Minimal systemic absorption when properly applied 8
  • Requires healthcare provider administration

Salonpas Patches

  • Generally well-tolerated for short-term use
  • Salicylate absorption possible—caution with aspirin allergy or anticoagulation
  • Not studied for long-term use

Clinical Decision Algorithm

For neuropathic pain:

  1. First-line: Lidocaine 5% patches for localized neuropathic pain, especially postherpetic neuralgia or diabetic neuropathy with allodynia 3, 4
  2. Second-line or severe cases: Capsaicin 8% patches for more severe or refractory peripheral neuropathic pain (HIV neuropathy, postherpetic neuralgia, diabetic neuropathy) 5, 3
  3. Trial lidocaine for at least 4 weeks before switching 6

For musculoskeletal pain:

  1. Salonpas patches appropriate for mild-to-moderate acute musculoskeletal pain (sprains, muscle soreness)
  2. Consider topical NSAIDs (diclofenac gel/patch) for osteoarthritis instead—stronger evidence base 12

Key distinction: The 2025 Lancet meta-analysis shows lidocaine has NNT=14.5 (very low certainty) while capsaicin 8% has NNT=13.2 (moderate certainty) for neuropathic pain 3. However, lidocaine's superior safety profile and ease of use justify first-line positioning for most patients, reserving capsaicin 8% for inadequate responders or severe cases.

Common Pitfalls

  • Don't use Salonpas for neuropathic pain—no evidence base; mechanism is counterirritant, not neuropathic pain-specific
  • Don't apply capsaicin 8% without lidocaine pretreatment—significantly increases tolerability 5
  • Don't exceed one Salonpas patch at a time (FDA warning) but can use up to 4 lidocaine patches safely 1
  • Don't expect immediate results with lidocaine—trial for 4 weeks minimum 6
  • Don't dismiss capsaicin 8% after first failure—consider second application 10
  • Lidocaine patches are not for wound care despite off-label use 1

References

Guideline

pharmacological management of persistent pain in older persons.

Journal of the American Geriatrics Society (JAGS), 2009

Guideline

adult cancer pain.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Related Questions

How does a high‑dose capsaicin 8% patch compare to a lidocaine 5% patch for the treatment of neuropathic pain?
How should Theraworx Nerve Relief Topical Foam be used for peripheral nerve discomfort and what are its contraindications?
What are the recommendations for using an 8% capsaicin patch in adult patients with localized peripheral neuropathic pain?
In patients with localized peripheral neuropathic pain, how does a capsaicin 0.05% topical patch compare to a lidocaine 5% patch regarding indications, application, tolerability, and contraindications?
Is Theraworx Nerve Relief topical foam safe for daily use and what is the recommended dosing regimen?
What dietary advice should be given to a pregnant patient to meet increased energy, protein, iron, calcium, and vitamin requirements?
What is the recommended propranolol regimen for adult patients with compensated cirrhosis and medium-to-large esophageal varices?
Is it necessary to taper off propranolol?
In a patient with multiple sclerosis who experiences new‑onset vertigo episodes lasting 20–30 minutes in the morning over the past 3–4 weeks, with prior episodes months apart, what additional tests, besides the Dix‑Hallpike maneuver, should be performed to differentiate a peripheral inner‑ear cause from a central CNS cause?
How should BioFreeze topical analgesic spray be used for short‑term relief of muscle, joint or back pain, including dosage, application frequency, contraindications, and potential side effects?
How should quetiapine (Seroquel) be titrated for a patient who has been on 100 mg daily for 7 days for mood stabilization and insomnia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.